Evidence map›Paper›PMID 32792488›Full record

ArticleNature communications2020

ABHD11 maintains 2-oxoglutarate metabolism by preserving functional lipoylation of the 2-oxoglutarate dehydrogenase complex.

Peter S J Bailey, Brian M Ortmann, Anthony W Martinelli, Jack W Houghton, Ana S H Costa, Stephen P Burr, Robin Antrobus, Christian Frezza, James A Nathan

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Nitrosylation rewires metabolism.Nature chemical biology · 2023
    Article
  19. Article
  20. The effect of HIF on metabolism and immunity.Nature reviews. Nephrology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Peter S J BaileyCambridge Institute for Medical Research, Department of Medicine, University of Cambridge, Cambridge, CB2 0XY, UK.ORCID http://orcid.org/0000-0001-7707-3521
Brian M OrtmannCambridge Institute for Medical Research, Department of Medicine, University of Cambridge, Cambridge, CB2 0XY, UK.
Anthony W MartinelliCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, CB2 0AW, UK.ORCID http://orcid.org/0000-0002-7285-7498
Jack W HoughtonCambridge Institute for Medical Research, Department of Medicine, University of Cambridge, Cambridge, CB2 0XY, UK.ORCID http://orcid.org/0000-0002-2971-0271
Ana S H CostaMRC Cancer Unit, University of Cambridge, Cambridge, CB2 0XZ, UK.ORCID http://orcid.org/0000-0001-8932-6370
Stephen P BurrCambridge Institute for Medical Research, Department of Medicine, University of Cambridge, Cambridge, CB2 0XY, UK.
Robin AntrobusCambridge Institute for Medical Research, Department of Medicine, University of Cambridge, Cambridge, CB2 0XY, UK.
Christian FrezzaMRC Cancer Unit, University of Cambridge, Cambridge, CB2 0XZ, UK.ORCID http://orcid.org/0000-0002-3293-7397
James A NathanCambridge Institute for Medical Research, Department of Medicine, University of Cambridge, Cambridge, CB2 0XY, UK. jan33@cam.ac.uk.ORCID http://orcid.org/0000-0002-0248-1632
University of Cambridge · GB

Funding

Department of HealthMedical Research Council MC_UU_12022/6Medical Research Council MRC_MC_UU_12022/6Wellcome TrustWellcome Trust 100140Wellcome Trust 102770/Z/13/ZWellcome Trust 205252/Z/16/ZWellcome Trust 215477/Z/19/Z
6 · The paper itself

Abstract

2-oxoglutarate (2-OG or α-ketoglutarate) relates mitochondrial metabolism to cell function by modulating the activity of 2-OG dependent dioxygenases involved in the hypoxia response and DNA/histone modifications. However, metabolic pathways that regulate these oxygen and 2-OG sensitive enzymes remain poorly understood. Here, using CRISPR Cas9 genome-wide mutagenesis to screen for genetic determinants of 2-OG levels, we uncover a redox sensitive mitochondrial lipoylation pathway, dependent on the mitochondrial hydrolase ABHD11, that signals changes in mitochondrial 2-OG metabolism to 2-OG dependent dioxygenase function. ABHD11 loss or inhibition drives a rapid increase in 2-OG levels by impairing lipoylation of the 2-OG dehydrogenase complex (OGDHc)-the rate limiting step for mitochondrial 2-OG metabolism. Rather than facilitating lipoate conjugation, ABHD11 associates with the OGDHc and maintains catalytic activity of lipoyl domain by preventing the formation of lipoyl adducts, highlighting ABHD11 as a regulator of functional lipoylation and 2-OG metabolism.

Indexed as

Energy MetabolismHeLa CellsHumansKetoglutarate Dehydrogenase ComplexKetoglutaric AcidsMitochondriaModels, BiologicalMutagenesisSerine ProteasesABHD11 protein, humanKetoglutarate Dehydrogenase ComplexKetoglutaric AcidsSerine Proteases

Identifiers

PMID32792488
PMCPMC7426941
OpenAlexW3048567590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.